Erik L. Ridley and Frances Rylands-Monk

Conference
GE HealthCare focuses on upgrades and 'experiences' at ECR 2023
VIENNA - At ECR 2023, GE HealthCare showcased a range of new imaging hardware and software, as well as "immersive experiences." For the first time, it participated in an ECR as an independent public traded company.
March 4, 2023
2022 01 21 00 30 1990 Ge Rsna 2021 400
Page 1 of 1
Top Stories
Shown is a 69-year-old man with a cholangiocarcinoma in the distal common bile duct. F-18 FDG-PET/CT was negative where Ga-68 FAPI-46 PET/CT showed high focal FAPI uptake in the liver hilum and surrounding lymph nodes. a-d: F-18 FDG-PET/CT, e-h: Ga-68 FAPI-46 PET/CT. a, b, e, f: Maximum intensity projections, c, g: axial fusion images, d, h: non-contrast enhanced CT.
Molecular Imaging
FAPI-PET/CT shows promise in hepatopancreatobiliary cancers
FAPI-PET/CT could potentially improve noninvasive cancer staging, and, ultimately, clinical decision making.
Shutterstock 1918864388
Womens Imaging
AI performs well in breast screening, but density complicates the picture
Photo 2026 06 19 10 08 34
Interventional
Lviv hosts second cardiovascular forum: From imaging to wartime medicine
Pexels Tara Winstead 7723619
MRI
Are European pilot sites ready for organized prostate cancer screening?
Pexels Szaboviktor 7662060
Radiology Education
Social media holds promise for radiology education
More in Home
FAPI-PET/CT shows promise in hepatopancreatobiliary cancers
By Will Morton
FAPI-PET/CT could potentially improve noninvasive cancer staging, and, ultimately, clinical decision making.
August 13, 2026
Shown is a 69-year-old man with a cholangiocarcinoma in the distal common bile duct. F-18 FDG-PET/CT was negative where Ga-68 FAPI-46 PET/CT showed high focal FAPI uptake in the liver hilum and surrounding lymph nodes. a-d: F-18 FDG-PET/CT, e-h: Ga-68 FAPI-46 PET/CT. a, b, e, f: Maximum intensity projections, c, g: axial fusion images, d, h: non-contrast enhanced CT.
AI performs well in breast screening, but density complicates the picture
By Claudia Tschabuschnig
While AI can support breast cancer risk assessment, its performance declined as breast density increased, while variations related to equipment vendor and measurement level may complicate personalized screening.
August 13, 2026
Shutterstock 1918864388
Lviv hosts second cardiovascular forum: From imaging to wartime medicine
MCI Lviv 2026 brought Ukrainian and international specialists together for two days of practical education and scientific exchange.
August 12, 2026
Photo 2026 06 19 10 08 34
Are European pilot sites ready for organized prostate cancer screening?
By Claudia Tschabuschnig
European pilot sites have the clinical capacity for risk-stratified prostate cancer screening but lack the infrastructure needed for implementation, a study found.
August 11, 2026
Pexels Tara Winstead 7723619
Social media holds promise for radiology education
By Claudia Tschabuschnig
A new scoping review finds strong interest in using social media for radiology education, but limited evidence that it measurably improves knowledge or performance.
August 10, 2026
Pexels Szaboviktor 7662060
CT 5-star quality rating system supports optimization
By Will Morton
The rating framework demonstrated robust reproducibility, with three-reader concordance reaching up to 93% in highly standardized centers.
August 7, 2026
Radiation Symbol
Jaap Stoker: AI can assist reviewers, but novelty remains human
By Claudia Tschabuschnig
Incoming European Radiology Experimental Editor-in-Chief Prof. Jaap Stoker gives insights into his new role and the future of scientific publishing.
August 6, 2026
Stoker222
Amyloid PET scores vary with reference-region choice, Spanish study finds
By Claudia Tschabuschnig
A Spanish study found that the brain region used as a reference can substantially alter Centiloid scores, while whole-cerebellum normalization produced the most consistent results.
August 5, 2026
Representative amyloid PET images acquired with flutemetamol, florbetaben, and florbetapir across a range of Centiloid values.
Multi-organ MRI shows no added benefit in major UK Long COVID trial
By Claudia Tschabuschnig
A major UK trial found no benefit from routinely adding multi-organ MRI to specialist Long COVID care. Abnormalities were detected, but fatigue and quality of life did not improve.
August 4, 2026
Fatigue is one of the most common and debilitating symptoms of Long COVID.
Europe’s lung screening training gaps sharpen focus on implementation
By Claudia Tschabuschnig
A new SOLACE survey reveals wide variation in lung cancer screening training across Europe, underscoring the need for harmonized standards and coordinated care pathways.
August 3, 2026
Lung Cancer Stages 400
EBR accepts registrations for EDiR, launches EDiR Academy
By AuntMinnieEurope.com staff writers
July 31, 2026
Doctors Residents Student Education 400
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
By Claudia Tschabuschnig
A Dutch study found that adding metabolic imaging to contrast-enhanced CT improved early detection of local tumor progression after liver ablation or resection, including disease missed by CT alone.
July 30, 2026
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
Page 1 of 89
Next Page